1400 Yaba drug tablets seized from Rohingyas

Image
ANI Hyderabad (Telangana) [India]
Last Updated : Jan 12 2019 | 5:50 AM IST

1400 tablets of banned Yaba Drugs have been seized from the alleged possession of two Rohingyas, police said on Friday.

Mahesh M Bhagwat, Commissioner of police, Rachakonda Commissionerate, Speaking to ANI said, "Today in the morning we got specific information that two Myanmar nationals (Rohingyas) are selling banned drugs. Based on the info the police staff of Balapur conducted searches and two accused persons by name Abibus Rehman and Mohd Rahim were apprehended. From their possession around 1400 tablets of banned drug by name Yaba drug which is also known as mad drug has been seized."

"This drug is mainly imported from Thailand and Myanmar countries. We have also seized an Aadhaar card from Mohd Raheem with Uttar Pradesh address. We are investigating the matter further. The total worth of the seizure is more than two lakhs. In Hyderabad this is the first time we have come across such incident," he added.

A case has been filed under Sections 8 (c) Read With 20 (i) A of NDPS Act 1985 and 199, 200, 420 IPC on the accused persons. The police is further investigating as to from where the accused persons have purchased this drug. They were allegedly selling each tablet for around Rs. 150.

Yaba drug is a mix of chemical substances like Cathine and Methamphetamine which is a narcotic drug and banned in India.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 12 2019 | 5:50 AM IST

Next Story